To view this email as a web page, click here.
 
The least expensive biologic in dermatology
A new study shows that brodalumab is the least expensive biologic option with high efficacy for moderate-to-severe plaque psoriasis in the United States.
ADVERTISEMENT
 
Pros and cons of physician payment models
Existing physician reimbursement models are a springboard for creating improved models that better align the practice management goals of dermatologists with patient care. "One of the best ways for dermatologists to prepare for a changing payment landscape is to educate themselves on current models of physician reimbursement in order to contribute to shaping emerging payment reform," says Dr. Vinod Nambudiri.
ADVERTISEMENT
 
Work better, not harder
As regulatory demands and office expenses increase, insurance reimbursement seems flat or on a slow decline, says Howard Wooding Rogers, M.D.
ADVERTISEMENT
 
JOB OPPORTUNITIES
 
AZ - Integrated Dermatology
CO - Leavitt Management Group
CO - Leavitt Management Group
CT - Integrated Dermatology
CT - Integrated Dermatology
CT - Integrated Dermatology
CT - Integrated Dermatology
FL - Integrated Dermatology
FL - Integrated Dermatology
FL - Leavitt Management Group
FL - Leavitt Management Group
FL - Leavitt Management Group
FL - Leavitt Management Group
GA - Leavitt Management Group
IL - Integrated Dermatology
MA - Integrated Dermatology
MA - Integrated Dermatology
MA - Integrated Dermatology
MD - Integrated Dermatology
MD - Integrated Dermatology
MD - Integrated Dermatology
MI - Leavitt Management Group
MI - Leavitt Management Group
National - Integrated Dermatology
NC - Integrated Dermatology
NJ - Integrated Dermatology
OR - Cynthia Dreyer MD
PA - Leavitt Management Group
PA - Integrated Dermatology
PA - Milton S Hershey Medical Center
RI - Leavitt Management Group
TN - Integrated Dermatology
TX - Company Confidential
VA - Integrated Dermatology
WY - Leavitt Management Group
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.